Feasibility and impact of a mental health chatbot on postpartum mental health: a randomized controlled trial

爱丁堡产后忧郁量表 心理健康 医学 随机对照试验 心情 焦虑 人口 病人健康调查表 聊天机器人 萧条(经济学) 产后抑郁症 干预(咨询) 精神科 怀孕 抑郁症状 经济 遗传学 外科 生物 环境卫生 宏观经济学 人工智能 计算机科学
作者
Sanaa Suharwardy,Maya Ramachandran,Stephanie A. Leonard,Anita Gunaseelan,Deirdre J. Lyell,Alison Darcy,Athena Robinson,Amy Judy
出处
期刊:AJOG global reports [Elsevier BV]
卷期号:3 (3): 100165-100165 被引量:81
标识
DOI:10.1016/j.xagr.2023.100165
摘要

BACKGROUND: Perinatal mood disorders are common yet underdiagnosed and un- or undertreated. Barriers exist to accessing perinatal mental health services, including limited availability, time, and cost. Automated conversational agents (chatbots) can deliver evidence-based cognitive behavioral therapy content through text message-based conversations and reduce depression and anxiety symptoms in select populations. Such digital mental health technologies are poised to overcome barriers to mental health care access but need to be evaluated for efficacy, as well as for preliminary feasibility and acceptability among perinatal populations. OBJECTIVE: To evaluate the acceptability and preliminary efficacy of a mental health chatbot for mood management in a general postpartum population. STUDY DESIGN: An unblinded randomized controlled trial was conducted at a tertiary academic center. English-speaking postpartum women aged 18 years or above with a live birth and access to a smartphone were eligible for enrollment prior to discharge from delivery hospitalization. Baseline surveys were administered to all participants prior to randomization to a mental health chatbot intervention or to usual care only. The intervention group downloaded the mental health chatbot smartphone application with perinatal-specific content, in addition to continuing usual care. Usual care consisted of routine postpartum follow up and mental health care as dictated by the patient's obstetric provider. Surveys were administered during delivery hospitalization (baseline) and at 2-, 4-, and 6-weeks postpartum to assess depression and anxiety symptoms. The primary outcome was a change in depression symptoms at 6-weeks as measured using two depression screening tools: Patient Health Questionnaire-9 and Edinburgh Postnatal Depression Scale. Secondary outcomes included anxiety symptoms measured using Generalized Anxiety Disorder-7, and satisfaction and acceptability using validated scales. Based on a prior study, we estimated a sample size of 130 would have sufficient (80%) power to detect a moderate effect size (d=.4) in between group difference on the Patient Health Questionnaire-9. RESULTS: A total of 192 women were randomized equally 1:1 to the chatbot or usual care; of these, 152 women completed the 6-week survey (n=68 chatbot, n=84 usual care) and were included in the final analysis. Mean baseline mental health assessment scores were below positive screening thresholds. At 6-weeks, there was a greater decrease in Patient Health Questionnaire-9 scores among the chatbot group compared to the usual care group (mean decrease=1.32, standard deviation=3.4 vs mean decrease=0.13, standard deviation=3.01, respectively). 6-week mean Edinburgh Postnatal Depression Scale and Generalized Anxiety Disorder-7 scores did not differ between groups and were similar to baseline. 91% (n=62) of the chatbot users were satisfied or highly satisfied with the chatbot, and 74% (n=50) of the intervention group reported use of the chatbot at least once in 2 weeks prior to the 6-week survey. 80% of study participants reported being comfortable with the use of a mobile smartphone application for mood management. CONCLUSION: Use of a chatbot was acceptable to women in the early postpartum period. The sample did not screen positive for depression at baseline and thus the potential of the chatbot to reduce depressive symptoms in this population was limited. This study was conducted in a general obstetric population. Future studies of longer duration in high-risk postpartum populations who screen positive for depression are needed to further understand the utility and efficacy of such digital therapeutics for that population.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Wxj246801完成签到,获得积分10
刚刚
Rampant发布了新的文献求助10
刚刚
CHENXIN532发布了新的文献求助10
2秒前
凯蒂jiang完成签到,获得积分10
2秒前
2秒前
3秒前
乐乐的应助被开心德地采纳,获得10
4秒前
李爱国的应助被树123采纳,获得10
4秒前
爱听歌盼海完成签到 ,获得积分10
4秒前
脑洞疼的应助被砍柴少年采纳,获得10
5秒前
英姑的应助被砍柴少年采纳,获得10
5秒前
木木夕的应助被ke采纳,获得10
6秒前
如风随水的应助被12111采纳,获得10
6秒前
HOHO完成签到,获得积分10
6秒前
CHENXIN532完成签到,获得积分10
7秒前
azkl完成签到,获得积分10
8秒前
Spring发布了新的文献求助10
9秒前
9秒前
10秒前
暮雪发布了新的文献求助10
10秒前
Cunese完成签到,获得积分10
11秒前
shirabuki完成签到,获得积分10
12秒前
ysan完成签到,获得积分10
12秒前
丘比特的应助被开心德地采纳,获得10
12秒前
如此发布了新的文献求助10
12秒前
Miles的应助被kangkang采纳,获得10
14秒前
14秒前
Lian发布了新的文献求助10
16秒前
17秒前
111发布了新的文献求助10
17秒前
科研通AI6.2的应助被zz采纳,获得10
17秒前
华仔的应助被amiee采纳,获得10
19秒前
deli完成签到,获得积分10
20秒前
wwrrqq发布了新的文献求助10
20秒前
ai完成签到,获得积分20
20秒前
彭于晏的应助被开心德地采纳,获得10
20秒前
21秒前
22秒前
25秒前
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188617
求助须知:如何正确求助?哪些是违规求助? 9576328
关于积分的说明 21846790
捐赠科研通 7786606
什么是DOI,文献DOI怎么找? 3435356
关于科研通互助平台的介绍 2559627
邀请新用户注册赠送积分活动 2482347